A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals
败血症过渡计划可降低高危人群的发病率和死亡率
基本信息
- 批准号:10835864
- 负责人:
- 金额:$ 56.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-23 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdoptionAdultAnxietyAreaBenchmarkingCaringCessation of lifeChronicClinicalCognitiveCommunicationComplexConsolidated Framework for Implementation ResearchCost AnalysisCost Effectiveness AnalysisDataData MartDevelopmentDissemination and ImplementationEarly identificationEffectivenessEligibility DeterminationEthnographyEvaluationEvidence based practiceFaceFunctional disorderGeographic LocationsGoalsHealthHealth Care CostsHealth Services AccessibilityHealth care facilityHealth systemHealthcareHealthcare ActivityHealthcare SystemsHospital MortalityHospitalizationHospitalsImpact evaluationImpaired healthImpairmentInstitutionInterventionKnowledgeLinkManaged CareMedication ErrorsMental DepressionMental HealthMethodsModelingMonitorMorbidity - disease rateNorth CarolinaNursesOrganOutcomePalliative CareParticipantPatient AdmissionPatient CarePatient-Focused OutcomesPatientsPharmaceutical PreparationsPopulationPopulation HeterogeneityPost-Traumatic Stress DisordersPrimary InfectionProcessProviderPublic HealthQuality-Adjusted Life YearsRandomizedRecommendationRecoveryResearchResearch DesignResearch MethodologyResolutionResourcesRiskRoleSepsisServicesSiteSurvivorsSystemTechnologyTestingTimeUnited StatesWorkacute careagedarmcare burdencare coordinationcare providersclinical practiceclinically significantcomorbiditycontextual factorscostcost effectivecost effectivenessdata warehousedesigneconomic evaluationeffectiveness evaluationelectronic health record systemevidence baseexperiencefuture implementationhealth care deliveryhealth care settingshigh riskhigh risk populationhospital carehospital readmissionimplementation evaluationimplementation facilitationimplementation strategyimprovedintervention programmortalitypoint of careprematureprogramsprospectivepublic health prioritiesrandomized, controlled studyrisk prediction modelseptic patientssocietal coststelehealthtreatment as usualvirtualvirtual healthcare
项目摘要
PROJECT SUMMARY
Sepsis survivors and healthcare systems are burdened by high mortality, morbidity, and utilization following
hospitalization for sepsis. While many complications post-sepsis result from preventable causes, healthcare
systems lack efficient strategies to deliver evidence-based care recommendations targeted to specific deficits
experienced by sepsis survivors. There is urgent need to determine successful implementation strategies for
post-sepsis care to improve patient outcomes. The overarching goal of our work is to reduce hospital
readmissions and post-discharge mortality for patients admitted to an acute care facility for sepsis. The
objective of this study is to evaluate the effectiveness and cost-effectiveness of implementing an evidence-
based Sepsis Transition And Recovery (STAR) program to develop broadly generalizable knowledge on best
practices for post-sepsis care. To achieve this objective, we will: 1) link EHR based data to risk prediction
algorithms to identify at the point of care patients who are high risk for post-sepsis mortality and readmission;
and 2) implement evidence-based post-sepsis care recommendations, directed to high-risk sepsis survivors,
and delivered using a proactive, nurse navigation process. The STAR program will focus on adults aged 18
and older hospitalized for sepsis. Effectiveness of the STAR program is assessed using a stepped-wedge,
cluster randomized controlled study design. Eight acute care hospitals from diverse geographic regions of
western and central North Carolina will be randomized to a staggered sequence (i.e., steps 1 to 8) of
transitioning from Usual Care to STAR group assignment. The two intervention conditions are: Arm 1) Usual
care in which hospitals and their providers have no access to intervention-related post-sepsis care support;
and Arm 2) STAR program intervention in which a centrally located nurse navigator facilitates the application of
four evidence-based core components of post-sepsis care (i.e., review of medications, new impairments,
comorbidities, and palliative care), to patients prior to and during the 90 days after hospital discharge. With
eight hospital sites and 4400 potentially eligible patients, this study will formally test the hypothesis that STAR
program implementation is superior to usual care with respect to significantly lower rate of combined death or
hospital readmission, at 90 days. We further hypothesize that STAR will have lower healthcare and societal
costs than usual care. We will use the Consolidated Framework for Implementation Research processes to
guide implementation planning, organization, conduct, and impact evaluation of this complex intervention into a
large, diverse healthcare system. We will apply focused ethnography to obtain an intensive and nuanced
understanding of the nurse navigator’s important role in the execution of the STAR program. The proposed
project will engage a heterogeneous population with substantial morbidity and mortality and gaps in the
delivery of evidence-based post-sepsis care. Results will advance dissemination and implementation research
methods that can improve the immense long-term healthcare burden of sepsis.
项目总结
败血症幸存者和医疗保健系统承受着高死亡率、发病率和使用率的负担
因败血症住院治疗。虽然败血症后的许多并发症是由可预防的原因造成的,但医疗保健
系统缺乏有效的策略来提供针对特定缺陷的循证护理建议
败血症幸存者所经历的。迫切需要确定以下方面的成功实施战略
败血症后护理以改善患者预后。我们工作的首要目标是减少医院
住进急性脓毒症护理机构的患者的再入院和出院后死亡率。这个
这项研究的目的是评估实施证据的有效性和成本效益-
基于脓毒症过渡和恢复(STAR)计划,开发关于BEST的概括性知识
败血症后护理的实践。为了实现这一目标,我们将:1)将基于EHR的数据与风险预测联系起来
在护理点识别败血症后死亡率和再入院高危患者的算法;
2)实施循证的败血症后护理建议,针对高危败血症幸存者,
并使用主动的护士导航流程进行交付。STAR计划的重点是18岁的成年人
以及年纪较大的人因败血症住院。STAR计划的有效性是使用阶梯楔子进行评估的,
整群随机对照研究设计。来自不同地理区域的八家急救医院
北卡罗来纳州西部和中部将被随机分成交错序列(即步骤1至8)
从日常护理过渡到明星团队任务。两种干预条件是:ARM 1)通常
医院及其提供者无法获得与干预相关的败血症后护理支持的护理;
和ARM 2)STAR计划干预,其中位于中心位置的护士导航器促进应用
败血症后护理的四个循证核心组成部分(即药物审查、新的损害、
患者在出院前和出院后90天内的合并症和姑息治疗)。使用
8个医院地点和4400名潜在符合条件的患者,这项研究将正式检验这一假设
方案实施优于常规护理,显著降低合并死亡率或
90天后再次入院。我们进一步假设,STAR将拥有较低的医疗保健和社会保障
费用比平时的护理要高。我们将使用实施研究过程综合框架来
指导实施规划、组织、实施和影响评估,将这一复杂干预措施纳入
大型、多样化的医疗保健系统。我们将应用聚焦的民族志来获得一个密集和细致入微的
了解护士导航员在实施STAR项目中的重要作用。建议数
该项目将吸引具有相当高发病率和死亡率的异质人口,并在
提供循证的败血症后护理。成果将推动传播和实施研究
可以改善败血症带来的巨大长期医疗负担的方法。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterizing Program Delivery for an Effective Multicomponent Sepsis Recovery Intervention.
描述有效的多成分脓毒症恢复干预计划交付的特征。
- DOI:10.1513/annalsats.202311-998oc
- 发表时间:2024
- 期刊:
- 影响因子:8.3
- 作者:Taylor,StephanieP;Morley,Claire;Donaldson,Megan;Samuel,Peter;Reed,Natalie;Noorali,Anika;Sutaria,Nirja;Zahr,Adam;Bray,Bethany;Kowalkowski,MarcA
- 通讯作者:Kowalkowski,MarcA
Effect of a Multicomponent Sepsis Transition and Recovery Program on Mortality and Readmissions After Sepsis: The Improving Morbidity During Post-Acute Care Transitions for Sepsis Randomized Clinical Trial.
- DOI:10.1097/ccm.0000000000005300
- 发表时间:2022-03-01
- 期刊:
- 影响因子:8.8
- 作者:
- 通讯作者:
Translating Postsepsis Care to Post-COVID-19 Care. The Case for a Virtual Recovery Program.
- DOI:10.1513/annalsats.202006-649ip
- 发表时间:2021-06
- 期刊:
- 影响因子:8.3
- 作者:Taylor SP;Rios A;Kowalkowski MA
- 通讯作者:Kowalkowski MA
Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS).
- DOI:10.1186/s12913-021-06521-1
- 发表时间:2021-06-02
- 期刊:
- 影响因子:2.8
- 作者:Kowalkowski M;Eaton T;McWilliams A;Tapp H;Rios A;Murphy S;Burns R;Gutnik B;O'Hare K;McCurdy L;Dulin M;Blanchette C;Chou SH;Halpern S;Angus DC;Taylor SP
- 通讯作者:Taylor SP
The Assessment of Social Determinants of Health in Postsepsis Mortality and Readmission: A Scoping Review.
脓毒症后死亡率和再入院健康社会决定因素的评估:范围界定审查。
- DOI:10.1097/cce.0000000000000722
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Hilton,RyanS;Hauschildt,Katrina;Shah,Milan;Kowalkowski,Marc;Taylor,Stephanie
- 通讯作者:Taylor,Stephanie
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marc Kowalkowski其他文献
Marc Kowalkowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marc Kowalkowski', 18)}}的其他基金
Personalized Clinical Decision Support to Improve Participation in Hospital at Home
个性化临床决策支持,提高在家就医的参与度
- 批准号:
10428461 - 财政年份:2021
- 资助金额:
$ 56.24万 - 项目类别:
COVID-19 Healthcare Access and Sequelae Evaluation
COVID-19 医疗保健获取和后遗症评估
- 批准号:
10320654 - 财政年份:2019
- 资助金额:
$ 56.24万 - 项目类别:
A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals
败血症过渡计划可降低高危人群的发病率和死亡率
- 批准号:
9982449 - 财政年份:2019
- 资助金额:
$ 56.24万 - 项目类别:
COVID-19 Healthcare Access and Sequelae Evaluation
COVID-19 医疗保健获取和后遗症评估
- 批准号:
10621400 - 财政年份:2019
- 资助金额:
$ 56.24万 - 项目类别:
A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals
败血症过渡计划可降低高危人群的发病率和死亡率
- 批准号:
10397042 - 财政年份:2019
- 资助金额:
$ 56.24万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 56.24万 - 项目类别:
Research Grant